Pre-Conference Day

Tuesday - 23 April, 2024

Morning Workshop with Roche
9am - 1pm

Predictive BMx Journey from Concept to Commercialization: Starting with the End in Mind

Join Roche for a morning of blended learning, with presentations, panel discussions, and group debate, covering key topics including:

- Commericialisation
- CDx Development - IVDR, Multi-Stage/Pan Tumor Approach
- Early BMx Discovery

Roche_Logo

Afternoon Thought Leadership Engager with Foundation Medicine
2pm - 4pm

Advancing Novel Biomarkers from Discovery through
Commercialization

Learn about innovative new biomarkers, like Foundation Medicine’s HRD signature and ctDNA tumor fraction, and how your essential diagnostics partner can support early biomarker discovery efforts through global clinical trial development and regulatory milestones

Expert speakers:

Colton Ballou, Associate Director Business Development, Foundation Medicine

Megan Townsend, Senior Manager, Foundation Medicine

fmi_logo

Evening Thought Leadership Engager with Quest
5pm - 7pm

Join us for a hosted learning and networking Engager in partnership with Quest Diagnostics.

Quest-Diagnostics-logo

*Attendance subject to availability & approval